Rivofonet Tablet

Rivofonet tablet contains Tenofovir Disoproxil Fumarate, an antiretroviral and antiviral medicine belonging to the nucleotide reverse transcriptase inhibitor (NRTI) class. It treats HIV (human immunodeficiency virus) and HBV (hepatitis B virus) infections by inhibiting the enzymes—HIV reverse transcriptase and hepatitis B DNA polymerase—that are necessary for viral replication. For HIV infection, this medicine must always be used in combination with other medicines. The tablet is suitable for adults and adolescents aged 12 to 18 years. In adolescents with HIV, it is indicated for those previously treated with other HIV medicines that are no longer fully effective due to resistance or have caused side effects. This tablet has not been studied in patients over 65 years of age.

Do not use Rivofonet tablet if you have experienced hypersensitivity reactions to Tenofovir Disoproxil Fumarate or any of its ingredients. During treatment, your doctor may periodically monitor your blood counts, bone mineral density, liver function, and kidney function parameters to prevent serious complications. Inform your doctor if you have a history of heart failure, pancreatitis, bone disease (osteonecrosis—death of bone tissue), fractures, liver disease (chronic hepatitis B or C), or kidney problems. Rivofonet tablet should not be given to adolescents with existing kidney problems. If you have lactose intolerance, notify your doctor before beginning treatment. Inform your doctor if you are planning to become pregnant, are pregnant, or think you may be pregnant. Breastfeeding is not recommended due to the potential transmission of HIV. Use effective contraception to prevent transmission of HIV infection from patients.

Treatment of HIV and HBV infections

The reverse transcriptase enzyme produces copies of DNA from the HIV’s RNA. Rivofonet tablet is a nucleotide analog that inhibits the reverse transcriptase enzyme and blocks DNA synthesis. It decreases the viral load of HIV in the blood and increases the number of CD4 (T) cells, enabling the immune system to fight other infections. This reduces the risk of severity and death associated with a weak immune system.

Rivofonet tablet is available as film-coated tablets in a dose of 300mg. The usual recommended dosage of this medication is one tablet every day, with or without food. For adults and children with body weight over 3.5kg, the usual recommended dose is 300mg per day. Your physician will choose the dosage and administration frequency based on the medical condition because it differs for each person.

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Serious Pancreas problems Kidney damage Deep, rapid breathing Drowsiness Nausea, vomiting Infection Lactic acidosis Common Headache Stomach pain Tiredness Bloating, flatulence Low phosphate levels in the blood Diarrhea Dizziness Rash Weakness

Inform your doctor about your underlying infections. If you have advanced HIV (AIDS), you may develop signs of infection and inflammation or worsening the signs of an existing infection once treatment is started. Report your doctor for side effects. It is very mandatory to tell your medical professional if you are consuming other medicines that may damage your kidneys. Always consume the dose recommended by your doctor. Rivofonet tablet does not reduce the risk of passing on HBV to others through sexual contact or blood contamination. You must continue the medication to avoid this complication.